Development of an Analytical Quality by Design‐Driven Impurity Control Strategy That Links Chromatographic Separation, Statistical Method Understanding, and Degradation Mechanism Characterization for Ivacaftor
SEPARATION SCIENCE PLUS · 2026-11 · 9 (11)
DOI: 10.1002/sscp.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift SEPARATION SCIENCE PLUS, online erschienen am 12.11.2026. Verfasst von Avinash Ramdas Pawar und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Ivacaftor, the first approved cystic fibrosis transmembrane conductance regulator potentiator, is administered chronically, making impurity control essential. This study developed an integrated analytical quality by design strategy combining DryLab‐assisted retention modelling, design of experiments method understanding with formal model adequacy testing, and degradation‐mechanism characterization with ICH M7(R2) risk assessment. DryLab scouting guided gradient development (mean absolute error 0.25 min; root‐mean‐squared error 0.33 min). A 15‐run Box–Behnken design augmented with 12 worst‐case corner runs identified formic acid concentration as the dominant factor; the interaction‐free quadratic was rejected ( p = 0.0537), and the full quadratic (27 runs) was formally adequate ( R 2 = 0.9996; lack‐of‐fit p = 0.96). An operating region of 0.07%–0.13% v/v formic acid, 37–43°C, and 0.50–0.70 mL min − 1 was verified at all boundaries and corners ( n = 3 per point); minimum predicted resolution 2.99 (95% bound 2.96) versus ≥2.5. The optimized method gave critical resolution 3.76, symmetry 1.00, and ∼14,200 plates. Validation per ICH Q2(R2): r 2 = 0.99980–0.99996, recoveries 98.8%–99.2%, precision ≤3.4% relative standard deviation, limit of quantification 0.114–0.120 µg mL − 1 for the two specified impurities. Forced degradation confirmed alkaline hydrolysis as dominant (10.1%; 97.06% mass balance; kobs = 3.33 × 10 − 3 min − 1 ); liquid chromatography‐high‐resolution tandem mass spectrometry identified four degradants, including the mass‐balanced amide‐hydrolysis pair. In silico (Quantitative) Structure–Activity Relationship flagged free‐aniline degradant DP‐alk‐1 as mutagenic; sensitivity validation with an authentic standard is ongoing.
Zitieren
APA
Pawar, A. R., & Pawar, S. P. (2026). Development of an Analytical Quality by Design‐Driven Impurity Control Strategy That Links Chromatographic Separation, Statistical Method Understanding, and Degradation Mechanism Characterization for Ivacaftor. SEPARATION SCIENCE PLUS, 9(11). https://doi.org/10.1002/sscp.70356
Vancouver
Pawar AR, Pawar SP. Development of an Analytical Quality by Design‐Driven Impurity Control Strategy That Links Chromatographic Separation, Statistical Method Understanding, and Degradation Mechanism Characterization for Ivacaftor. SEPARATION SCIENCE PLUS. 2026;9(11). doi:10.1002/sscp.70356
BibTeX
@article{Pawar2026,
author = {Pawar, Avinash Ramdas and Pawar, Sunil Pandit},
title = {Development of an Analytical Quality by Design‐Driven Impurity Control Strategy That Links Chromatographic Separation, Statistical Method Understanding, and Degradation Mechanism Characterization for Ivacaftor},
journal = {SEPARATION SCIENCE PLUS},
year = {2026},
volume = {9},
number = {11},
doi = {10.1002/sscp.70356}
}
EUVIMED